Gilead Sciences, Inc. - stock earnings

GILD Quarterly earnings

DateEarningsRevenue
2020Q3 360.0 million USD 6.6 billion USD
2020Q4 1.6 billion USD 7.4 billion USD
2021Q1 1.7 billion USD 6.4 billion USD
2021Q2 1.5 billion USD 6.2 billion USD
2021Q3 2.6 billion USD 7.4 billion USD
2021Q4 382.0 million USD 7.2 billion USD
2022Q1 19.0 million USD 6.6 billion USD
2022Q2 1.1 billion USD 6.3 billion USD
2022Q3 1.8 billion USD 7.0 billion USD

GILD Yearly earnings

DateEarningsRevenue
2017 4.6 billion USD 26.1 billion USD
2018 5.5 billion USD 22.1 billion USD
2019 5.4 billion USD 22.4 billion USD
2020 123.0 million USD 24.7 billion USD
2021 6.2 billion USD 27.3 billion USD

GILD

List: Challengers

Price: 85.50USD

52 week range price:
57.17
86.26

Dividend Yield: 3.51%

5-year range yield:
2.53%
5.05%

Forward Dividend Yield: 3.42%

Payout Ratio: 45.13%

Payout Ratio Range:
-1137.70%
2915.81%

Dividend Per Share: 2.92 USD

Earnings Per Share: 6.75 USD

P/E Ratio: 30.99

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers—General

Volume: 11.4 million

Ebitda: 2.4 billion

Market Capitalization: 102.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 8

DGR3: 7.62%

DGR5: 9.11%

Links: